Healthy lifestyle is highly linked to proper nutrition intake in the body, majorly for elder people aged 65 years or above. As per a report published by the World Health Organization (WHO), elder population suffers from diseases, out of which majority are resulted because of lack of elderly nutrition intake. Fat in food is associated with the cancer of colon, prostate and pancreas. Micronutrients linked improper nutrition result in degenerative diseases like diabetes and osteoporosis. The deficiency of micronutrients is common between the geriatric population owing it to factors like lack of variety in their diet and reduced food intake. Reduced ability for preparation of healthy foods and decreasing appetite result into lack of several major nutrients, like, minerals, vitamins and fibers, which could further result into general weakness or could also exacerbate chronic diseases. According to the estimates provided by the Alzheimer Association 2017 Report, approximately 13.8 million people in the U.S. were diagnosed with Alzheimer’s dementia, out of which majority was observed in elderly population above 65 years of age. A few age-related problems that obstruct elderly nutrition intake are, medication side effects, decreased sensitivity, lack of finances, poor dental health, lack of transportation, memory loss, physical difficulty, and depression.
Constant increase in the geriatric population is one of the major factors that is expected to contribute to the growth of elderly nutrition market during the forecast period. There is a consistent rise in the elderly population prone to various neurological and chronic diseases and lack elderly nutritional intake. Increasing incidences of sarcopenia, organ dysfunction, age-related low immunity and osteoporosis, specifically for older women, are expected to fuel the market growth for elderly nutrition. Rise in market manufacturers investing in R&D for the development of novel materials for elderly nutrition intake is also expected to contribute to the elderly nutrition market. However, lack of finances, risks associated with parenteral elderly nutrition therapy, such as, liver dysfunction, and re-feeding syndrome is expected to restrain market growth for elderly nutrition during the forecast period.
Tentatively, Elderly Nutrition Market has been segmented on the basis of product type, application, and end user.
On the basis of Nutrition Type, Elderly Nutrition Market can be segmented as:
On the basis of Route of Administration, Elderly Nutrition Market can be segmented as:
On the basis of Application, Elderly Nutrition Market can be segmented as:
- Renal Failures
On the basis of Distribution Channel, Elderly Nutrition Market can be segmented as:
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
- Hypermarkets & Supermarkets
- Drug Stores
Global Elderly Nutrition market is expected to propel during the forecast factors, owing it to rapid increase in elderly population and growing number of elderly nutrition providers. Marker players operating in the elderly nutrition market are highly focused on development of improved and advanced products for addressing unmet needs of the elderly population. Ensure Max Protein, a product range by Abbott, was launched in April, 2018, for elderly nutrition intake. The product offered includes 9 essential amino acids, minerals, 22 vitamins, and antioxidants like, vitamin D, vitamin C, and vitamin E. The elderly nutrition market is also attributed to various launched and approvals of products specific to neurological disorders. Nutricia, a market manufacturer for elderly nutrition products launched Souvenaid in 2012, which is used for dietary management of early Alzheimer’s disease.
Europe’s Elderly Nutrition market is expected to grow at a significant rate, owing it to the high prevalence rates of chronic illnesses, like, cardiovascular diseases, cancer, and other renal disorders. As per the European Heart Network factsheet, 2017, approximately 11.3 million incidence cases of cardiovascular diseases were reported in the region. Improvements in the healthcare expenditure in the region is also one of the major factors boosting the market for elderly nutrition in the region. Developed regions like North America, have high rates of geriatric population and there is a consistent rise in the disposable income, which is further projected to fuel the market growth for elderly nutrition in the region.
Some of the market participants in the Global Elderly Nutrition market identified across the value chain include: Otsuka Pharmaceuticals Co., Ltd., Allergan, Nutricia, Danone, Abbott, Mead Johnson & Company, LLC, Pfizer, Inc., Sanofi, Nestlé’s, GlaxoSmithKline, Sichuan Kelun Pharmaceutical Company Limited, and Fresenius Kabi USA.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report on elderly nutrition provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Argentina, Mexico, Brazil)
- Europe (Germany, Italy, U.K, Spain, France, Russia, Poland)
- Asia Pacific Excluding Japan (India, Australia & New Zealand, China, ASEAN)
- Middle East and Africa (GCC, South Africa, Rest Of MEA)
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.